Indivior Pharmaceuticals Inc (INDV) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Indivior Pharmaceuticals Inc (INDV) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $4.78B, listed on NASDAQ, employing roughly 1,030 people, carrying a beta of 1.20 to the broader market. Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Led by Joseph J. Ciaffoni, public since 2014-12-29.
Snapshot as of May 15, 2026.
- Spot Price
- $36.67
- Total OI
- 28.1K
Learn how max pain is reported and how to read the data →
INDV highest open-interest contracts
| Type | Strike | Expiration | Volume | OI | IV | Bid | Ask |
|---|---|---|---|---|---|---|---|
| CALL | $40.00 | Aug 21, 2026 | 3 | 16.6K | 51.2% | $2.50 | $3.70 |
Top 1 contracts from the ORATS-sourced nightly scan; ranked by oi within the broader S&P 500/400/600 + ETF universe.